Publication | Open Access
<scp>PEPD</scp>ar: A randomized prospective noninferiority study of ritonavir‐boosted darunavir for HIV post‐exposure prophylaxis
15
Citations
18
References
2016
Year
Noninferiority of DRV/r to SOC was demonstrated. DRV/r should be included as a standard component of recommended regimens in PEP guidelines.
| Year | Citations | |
|---|---|---|
Page 1
Page 1